We can’t rule out rare side effects or side effects that appear long after vaccination, the Norwegian Medicines Agency warns.
If everything goes according to plan, the first vaccine will receive temporary approval in Europe by New Year.
“There will be a lot we do not want to know at this time, and we demand that the vaccine manufacturers continue with their studies.
“Therefore, they will get temporary approval,” director of the Norwegian Medicines Agency Audun Hågå noted.
Among other things, answers are required on how the vaccine works on the elderly and whether rare side effects appear.
“We want to know a lot about common side effects in adults, but we can not rule out rare effects or side effects that appear long after vaccination,” Hågå stated.
© NTB Scanpix / #Norway Today